Moderna Inc

MRNA: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|t<LOCK|ssLOCK|FN<?p#M

Moderna Earnings: All Eyes on Upcoming Data for Oncology Therapy Intismeran

Moderna reported $389 million in revenue in the first quarter, but research and development spending and a $900 million legal settlement drove a $1.3 billion net loss. Moderna maintained guidance for up to 10% revenue growth in 2026. Shares fell 3% intraday on May 1.

Sponsor Center